THYROCAREHealthcare Service Provider
Thyrocare Technologies Ltd — Cash Flow Statement
₹349.55
-2.13%
Thyrocare Technologies Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Long Term Debt Issuance | 0.00 | 28.62 Cr | 0.00 | — | — |
| Investing Cash Flow | -52.52 Cr | -91.29 Cr | -38.99 Cr | -23.57 Cr | — |
| Interest Received Cfi | 1.97 Cr | 0.98 Cr | 1.30 Cr | 0.73 Cr | — |
| Net Investment Purchase And Sale | 1.64 Cr | -27.88 Cr | 1.26 Cr | -13.65 Cr | — |
| Sale Of Investment | 8.20 Cr | — | 193.25 Cr | 159.35 Cr | 104.21 Cr |
| Purchase Of Investment | -6.56 Cr | -27.88 Cr | -191.99 Cr | -173.00 Cr | — |
| Net Business Purchase And Sale | -11.25 Cr | -3.52 Cr | 0.00 | 4.25 Cr | — |
| Sale Of Business | 0.01 Cr | — | 0.00 | 4.25 Cr | 4.25 Cr |
| Purchase Of Business | -11.26 Cr | -3.52 Cr | 0.00 | — | — |
| Net PPE Purchase And Sale | -44.88 Cr | -60.86 Cr | -41.55 Cr | -14.90 Cr | — |
| Sale Of PPE | 0.01 Cr | 0.72 Cr | 2.10 Cr | 22.93 Cr | — |
| Purchase Of PPE | -44.89 Cr | -61.58 Cr | -43.65 Cr | -37.83 Cr | — |
| Operating Cash Flow | 191.32 Cr | 167.63 Cr | 129.31 Cr | 113.41 Cr | — |
| Taxes Refund Paid | -41.38 Cr | -28.99 Cr | -28.46 Cr | -56.76 Cr | — |
| Change In Working Capital | 12.54 Cr | 30.16 Cr | 5.79 Cr | -79.22 Cr | — |
| Change In Other Current Liabilities | 20.29 Cr | 0.38 Cr | -2.73 Cr | 6.71 Cr | — |
| Change In Other Current Assets | -15.35 Cr | 2.16 Cr | 5.18 Cr | -7.51 Cr | — |
| Change In Payable | 36.10 Cr | 16.12 Cr | 7.42 Cr | -8.48 Cr | — |
| Change In Inventory | 0.99 Cr | -19.85 Cr | -3.14 Cr | -1.17 Cr | — |
| Change In Receivables | -30.79 Cr | 32.82 Cr | -1.37 Cr | -58.76 Cr | — |
| Other Non Cash Items | 1.07 Cr | 3.22 Cr | 0.97 Cr | 1.66 Cr | — |
| Stock Based Compensation | 24.51 Cr | 16.67 Cr | 21.17 Cr | 2.32 Cr | — |
| Provisionand Write Offof Assets | 1.26 Cr | 8.83 Cr | 9.52 Cr | 10.20 Cr | — |
| Depreciation And Amortization | 55.26 Cr | 47.01 Cr | 38.71 Cr | 33.87 Cr | — |
| Amortization Cash Flow | 1.08 Cr | — | 0.84 Cr | — | — |
| Depreciation | 54.18 Cr | 47.01 Cr | 37.87 Cr | 33.87 Cr | — |
| Gain Loss On Investment Securities | -8.81 Cr | -5.79 Cr | -5.37 Cr | -5.22 Cr | — |
| Gain Loss On Sale Of PPE | -0.01 Cr | 0.93 Cr | -0.43 Cr | -19.39 Cr | — |
| Net Income From Continuing Operations | 146.88 Cr | 95.59 Cr | 87.41 Cr | 227.90 Cr | — |
| Free Cash Flow | 146.43 Cr | 106.05 Cr | 85.66 Cr | 75.58 Cr | — |
| Repayment Of Debt | -21.59 Cr | -7.03 Cr | 0.00 | 0.00 | — |
| Issuance Of Debt | 0.00 | 28.62 Cr | 0.00 | — | — |
| Issuance Of Capital Stock | 0.04 Cr | 0.02 Cr | 0.03 Cr | 0.03 Cr | — |
| Capital Expenditure | -44.89 Cr | -61.58 Cr | -43.65 Cr | -37.83 Cr | — |
| End Cash Position | 17.68 Cr | 9.30 Cr | 17.77 Cr | 13.63 Cr | — |
| Beginning Cash Position | 9.30 Cr | 17.77 Cr | 13.63 Cr | 13.20 Cr | — |
| Changes In Cash | 8.38 Cr | -8.47 Cr | 4.14 Cr | 0.43 Cr | — |
| Financing Cash Flow | -130.42 Cr | -84.81 Cr | -86.18 Cr | -89.41 Cr | — |
| Interest Paid Cff | -3.07 Cr | -6.64 Cr | -2.25 Cr | -4.75 Cr | — |
| Cash Dividends Paid | -95.31 Cr | -95.27 Cr | -79.35 Cr | -79.31 Cr | — |
| Common Stock Dividend Paid | -95.31 Cr | -95.27 Cr | -79.35 Cr | -79.31 Cr | — |
| Net Common Stock Issuance | 0.04 Cr | 0.02 Cr | 0.03 Cr | 0.03 Cr | — |
| Common Stock Issuance | 0.04 Cr | 0.02 Cr | 0.03 Cr | 0.03 Cr | — |
| Net Issuance Payments Of Debt | -21.59 Cr | 21.59 Cr | 0.00 | 0.00 | — |
| Net Long Term Debt Issuance | -21.59 Cr | 21.59 Cr | 0.00 | 0.00 | — |
| Long Term Debt Payments | -21.59 Cr | -7.03 Cr | 0.00 | 0.00 | — |
| Net Other Financing Charges | — | 1.21 Cr | 0.92 Cr | — | -0.01 Cr |
| Net Other Investing Changes | — | -0.01 Cr | 0.13 Cr | — | — |
| Other Cash Adjustment Outside Changein Cash | — | -0.01 Cr | — | — | 0.01 Cr |
| Repurchase Of Capital Stock | — | — | -5.53 Cr | -5.38 Cr | — |
| Common Stock Payments | — | — | -5.53 Cr | -5.38 Cr | — |
| Gain Loss On Sale Of Business | — | — | 0.00 | -1.95 Cr | -1.64 Cr |
| Dividends Received Cfi | — | — | — | — | 0.00 |
| Pension And Employee Benefit Expense | — | — | — | — | 1.68 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Thyrocare Technologies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.